Get started
Author

Abby L. Huckle

Observed names: A Huckle, A. Huckle, Abby Huckle, Huckle, Abby
OpenAlex ID: A5049319924
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 1,976
PDF
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 533
PDF
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 493
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 369
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 324
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 290
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 129
Vinculin is required to maintain glomerular barrier integrity
2017 · Franziska Lausecker, Xuefei Tian, et al. · Kidney International · 52
PDF
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39
PDF
Calciphylaxis in end-stage kidney disease: outcome data from the United Kingdom Calciphylaxis Study
2021 · Rajkumar Chinnadurai, Abby Huckle, et al. · Journal of Nephrology · 27
PDF
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12
PDF
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O. Abani, A. Abbas, et al. · EClinicalMedicine · 5
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2026 · Abani, O., Abbas, A., et al. · White Rose Research Online (University of Leeds, The University of Sheffield, University of York)
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases
PDF
Glucocorticoid Toxicity in the Ponticelli Regimen
2020 · Abby L. Huckle, Ajay P. Dhaygude · Journal of the American Society of Nephrology
Fc021natural History, Outcomes and Mortality Associations of Calciphylaxis: Data From the Uk Calciphylaxis Registry
2019 · Rajkumar Chinnadurai, Abby Huckle, et al. · Nephrology Dialysis Transplantation
Mp582uk Calciphylaxis Study: Interim Analysis
2017 · Abby Huckle, James Ritchie, et al. · Nephrology Dialysis Transplantation
PDF
Works count: 17
Citation count: 2,312
H-index: 11
I10-index: 11
Year
Topic
Type